FDA 483 - Paul A. Goepfert, MD. - November 20, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Paul A. Goepfert, MD, Principal Investigator, was inspected regarding a clinical study and found to have significant deficiencies in maintaining adequate case histories. The firm failed to obtain proper documentation for COVID-19 screening tests, lacked sufficient laboratory records for immunogenicity sample processing, and had incomplete subject eligibility information regarding participation in other clinical studies. These issues indicate serious concerns with data integrity and adherence to study protocols.
ID · 1f71a72e-e179-44cc-8a54-f30d1d9327c5